fcmedicineФундаментальная и клиническая медицинаFundamental and Clinical Medicine2500-07642542-0941КемГМУ10.23946/2500-0764-2026-11-1-74-81fcmedicine-1155Research ArticleКАРДИОЛОГИЯCARDIOLOGYСовременные подходы к реабилитации пациентов с сердечной недостаточностью. перспективы применения метода интервальных гипоксически-гипероксических тренировокModern approaches to rehabilitation of patients with heart failure. Prospects for using the interval hypoxic-hyperoxic training methodhttps://orcid.org/0009-0007-2788-0748СахарчукА. Ю.SakharchukA. Yu.

Сахарчук Алексей Юрьевич, ординатор 

бульвар имени академика Л.С. Барбараша, д. 6, г. Кемерово, 650002 

Dr. Alexey Yu. Sakharchuk, MD, cardiology resident 

Barbarash Boulevard, 6, Kemerovo, 650002 

alex90s03kemerovo@mail.ruhttps://orcid.org/0000-0003-2769-3807ЛебедеваН. Б.LebedevaN. B.

Лебедева Наталья Борисовна, доктор медицинских наук, доцент, ведущий научный сотрудник лаборатории реабилитации

бульвар имени академика Л.С. Барбараша, д. 6, г. Кемерово, 650002 

Dr. Nataliya B. Lebedeva, MD, Associate Professor, Leading Researcher, Laboratory of Rehabilitation

Barbarash Boulevard, 6, Kemerovo, 650002 

Научно-исследовательский институт комплексных проблем сердечно-сосудистых заболеванийРоссияResearch Institute for Complex Issues of Cardiovascular DiseasesRussian Federation2026220320261117481Copyright © Сахарчук А.Ю., Лебедева Н.Б., 20262026Сахарчук А.Ю., Лебедева Н.Б.Sakharchuk A.Y., Lebedeva N.B.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://fcm.kemsmu.ru/jour/article/view/1155Цель

Цель. Проанализировать современные подходы к реабилитации и оценить возможности и перспективы применения ИГГТ у пациентов с ХСН.

Материалы и методы

Материалы и методы. Проведен анализ научных публикаций, представленных в базах данных elibrary.ru, PubMed за период с 2014 по 2024 гг. по таким ключевым словам, как «гипоксическое воздействие, интервальные гипоксические тренировки, гипокси-гиперокситерапия, ре-окси терапия, патофизиологические механизмы гипоксии, кардиореабилитация». Критериями включения являлись результаты рандомизированных исследований, системные обзоры, а также оригинальные статьи с наличием контрольной группы.

Результаты

Результаты. Показано, что метод ИГГТ является перспективным направлением, который обладает патофизиологическим обоснованием и демонстрирует положительные результаты в клинических исследованиях.

Заключение

Заключение. Дальнейшее развитие и практическая интеграция этого метода требуют крупных рандомизированных исследований для подтверждения его клинической эффективности и безопасности.

Aim

Aim. The purpose of this review is to analyze modern approaches to rehabilitation and evaluate the possibilities and prospects of using the method of interval hypoxic-hyperoxic training (IGTT) in patients with CHF.

Materials and methods

Materials and methods. Analysis of scientific publications presented in databases elibrary.ru PubMed was conducted for the period from 2014 to 2024 on keywords such as "hypoxic effects, interval hypoxic training, hypoxic-hyperoxytherapy, re-oxy therapy, pathophysiological mechanisms of hypoxia, cardiorehabilitation." The inclusion criteria were the results of randomized trials, systematic reviews, as well as original articles with a control group.

Results

Results. It has been shown that the IGTT method is a promising direction that has a pathophysiological basis and demonstrates positive results in clinical trials.

Conclusions

Conclusions. Further development and practical integration of this method require large randomized trials to confirm its clinical efficacy and safety.

гипокси-гиперокситерапияре-окси терапияпатофизиологические механизмы гипоксиикардиореабилитацияhypoxy-hyperoxytherapyre-oxy therapypathophysiological mechanisms of hypoxiacardiorehabilitationReferencesСитникова М. Ю., Лясникова Е. А., Юрченко А. В., Трукшина М. А., Либис Р. А., Кондратенко В. Ю. и др. [Результаты Российского госпитального регистра хронической сердечной недостаточности в трех субъектах Российской Федерации]. Кардиология. 2015;55(10):5–13. https://doi.org/10.18565/cardio.2015.10.5-13Sitnikova MY, Lyasnikova EA, Yurchenko AV, Trukshina MA, Libis RA, Kondratenko VY, et al. [Results of Russian Hospital Chronic Heart Failure Registry in Three Subjects of Russian Federation]. Kardiologiia. 2015;55(10):5–13. (In Russ.). https://doi.org/10.18565/cardio.2015.10.5-13Vedin O., Lam C.S.P., Koh A.S., Benson L., Teng T.H.K., Tay W.T. et al. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study. Circ. Heart Fail. 2017;10(6):e003875. https://doi.org/10.1161/CIRCHEARTFAILURE.117.003875Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT, et al. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study. Circ Heart Fail. 2017;10(6):e003875. https://doi.org/10.1161/CIRCHEARTFAILURE.117.003875Dokainish H., Teo K., Zhu J., Roy A., AlHabib K.F., ElSayed A. et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob. Health. 2017;5(7):e665–e672. https://doi.org/10.1016/S2214-109X(17)30196Dokainish H, Teo K, Zhu J, Roy A, AlHabib KF, ElSayed A, et al. Global mortality variations in patients with heart failure: results from the International Congestive Heart Failure (INTER-CHF) prospective cohort study. Lancet Glob Health. 2017;5(7):e665–e672. https://doi.org/10.1016/S2214-109X(17)30196-1GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. https://doi.org/10.1016/S0140-6736(18)32279-7Virani S.S., Alonso A., Aparicio H.J., Benjamin E.J., Bittencourt M.S., Callaway C.W. et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254– e743. https://doi.org/10.1161/CIR.0000000000000950Virani SS, Alonso A, Aparicio HJ, Benjamin EJ, Bittencourt MS, Callaway CW, et al. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021;143(8):e254-e743. https://doi.org/10.1161/CIR.0000000000000950Popa I.P., Haba M.Ș.C., Mărănducă M.A., Tănase D.M., Șerban D.N., Șerban L.I. et al. Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives. Pharmaceutics. 2022;14(9):1964. https://doi.org/10.3390/pharmaceutics14091964Popa IP, Haba MȘC, Mărănducă MA, Tănase DM, Șerban DN, Șerban LI, et al. Modern Approaches for the Treatment of Heart Failure: Recent Advances and Future Perspectives. Pharmaceutics. 2022;14(9):1964. https://doi.org/10.3390/pharmaceutics14091964Фомин И. В. Хроническая сердечная недостаточность в Российской Федерации: что сегодня мы знаем и что должны делать. Российский кардиологический журнал. 2016;(8):7–13. https://doi.org/10.15829/1560-4071-2016-8-7-13Fomin IV. Chronic heart failure in Russian Federation: what do we know and what to do. Russian Journal of Cardiology. 2016;(8):7–13. (In Russ.). https://doi.org/10.15829/1560-4071-2016-8-7-13Российское кардиологическое общество (РКО). Хроническая сердечная недостаточность. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(11):4083. https://doi.org/10.15829/1560-4071-2020-4083Russian Society of Cardiology (RSC). 2020 Clinical practice guidelines for Chronic heart failur. Russian Journal of Cardiology. 2020;25(11):4083. (In Russ.). https://doi.org/10.15829/1560-4071-2020-4083Драпкина О. М., Бойцов С. А., Омельяновский В. В., Концевая А. В., Лукьянов М. М., Игнатьева В. И. и др. Социально-экономический ущерб, обусловленный хронической сердечной недостаточностью, в Российской Федерации. Российский кардиологический журнал. 2021;26(6):4490. https://doi.org/10.15829/1560-4071-2021-4490Drapkina OM, Boytsov SA, Omelyanovskiy VV, Kontsevaya AV, Loukianov MM, Ignatieva VI, et al. Socio-economic impact of heart failure in Russia. Russian Journal of Cardiology. 2021;26(6):4490. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4490Гиоева З. М., Богданов А. Р., Залетова Т. С., Богданова А. А. Ожирение как фактор риска развития хронической сердечной недостаточности (литературный обзор). Доктор. Ру. 2017;10(139):21–25. EDN: ZXWOHXGioeva ZM, Bogdanov AR, Zaletova TS, Bogdanova AA. Obesity as a Risk Factor for Chronic Heart Failure: A Review of the Literature. Doctor.Ru. 2017;10(139):21–25. (In Russ.).Pelliccia A., Sharma S., Gati S., Bäck M., Börjesson M., Caselli S., et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur. Heart J. 2021;42(1):17–96. https://doi.org/10.1093/eurheartj/ehaa605.Pelliccia A, Sharma S, Gati S, Bäck M, Börjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J. 2021;42(1):17–96. https://doi.org/10.1093/eurheartj/ehaa605.Packer M., Anker S.D., Butler J., Filippatos G., Ferreira J.P., Pocock S.J., et al. Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial. J. Am. Coll. Cardiol. 2021;77(11):1381–1392. https://doi.org/10.1016/j.jacc.2021.01.033.Packer M, Anker SD, Butler J, Filippatos G, Ferreira JP, Pocock SJ, et al. Empagliflozin in Patients With Heart Failure, Reduced Ejection Fraction, and Volume Overload: EMPEROR-Reduced Trial. J Am Coll Cardiol. 2021;77(11):1381–1392. https://doi.org/10.1016/j.jacc.2021.01.033.You G., Xie J., Tong W., Zhao Sh. The new perspective of cardiac exercise rehabilitation: based on integrative physiology. Front. Physiol. 2025;16:1651589. https://doi.org/10.3389/fphys.2025.1651589You G, Xie J, Tong W, Zhao Sh. The new perspective of cardiac exercise rehabilitation: based on integrative physiology. Front Physiol. 2025;16:1651589. https://doi.org/10.3389/fphys.2025.1651589Halpin S.J., McIvor C., Whyatt G., Adams A., Harvey O., McLean L., et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93(2):1013–1022. https://doi.org/10.1002/jmv.26368.Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J. Med. Virol. 2021;93(2):1013–1022. https://doi.org/10.1002/jmv.26368.Владимирский В. Е., Бобылев Ю. М. Реабилитация больных хронической сердечной недостаточностью: возможности и нерешенные проблемы. Пермский медицинский журнал. 2021;4:85–103. https://doi.org/10.17816/pmj38485%103Vladimirskiy VE, Bobylev YuM. Rehabilitation of patients with chronic heart failure: opportunities and unresolved issues. 2021;4:85–103 (In Russ.). https://doi.org/10.17816/pmj38485%103Writing Committee Members; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J. Card. Fail. 2022;28(5):e1–e167. https://doi.org/10.1016/j.cardfail.2022.02.010Writing Committee Members; ACC/AHA Joint Committee Members. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure. J Card Fail. 2022;28(5):e1–e167. https://doi.org/10.1016/j.cardfail.2022.02.010Heidenreich P.A., Bozkurt B., Aguilar D., Allen L.A., Byun J.J., Colvin M.M., et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2022;79(17):e263–e421. https://doi.org/10.1016/j.jacc.2021.12.012Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/ American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263–e421. https://doi.org/10.1016/j.jacc.2021.12.012Glazachev OS, Kryzhanovskaya SY, Zapara MA, Dudnik EN, Samartseva VG, Susta D. Safety and Efficacy of Intermittent Hypoxia Conditioning as a New Rehabilitation/ Secondary Prevention Strategy for Patients with Cardiovascular Diseases: A Systematic Review and Meta-analysis. Curr. Cardiol. Rev. 2021;17(6):e051121193317. https://doi.org/10.2174/1573403X17666210514005235Glazachev OS, Kryzhanovskaya SY, Zapara MA, Dudnik EN, Samartseva VG, Susta D. Safety and Efficacy of Intermittent Hypoxia Conditioning as a New Rehabilitation/ Secondary Prevention Strategy for Patients with Cardiovascular Diseases: A Systematic Review and Meta-analysis. Curr Cardiol Rev. 2021;17(6):e051121193317.https://doi.org/10.2174/1573403X17666210514005235Ларина В. Н., Ахматова Ф. Д., Аракелов С. Е., Мохов А. Е., Доронина И. М., Денисова Н. Н. [Современные стратегии кардиореабилитации после инфаркта миокарда и чрескожного коронарного вмешательства]. Кардиология. 2020;60(3):111–118. https://doi.org/10.18087/кардио.2020.3.n546Larina VN, Akhmatova FD, Arakelov SE, Mokhov AE, Doronina IM, Denisova NN. [Modern strategies for cardiac rehabilitation after myocardial infarction and percutaneous coronary intervention]. Kardiologiia. 2020;60(3):111–118. (Russ.). https://doi.org/10.18087/cardio.2020.3.n546Zaree A., Dev S., Yaseen Khan I., Arain M., Rasool S., Khalid Rana M.A., et al. Cardiac Rehabilitation in the Modern Era: Optimizing Recovery and Reducing Recurrence. Cureus. 2023;15(9):e46006. https://doi.org/10.7759/cureus.46006Zaree A, Dev S, Yaseen Khan I, Arain M, Rasool S, Khalid Rana MA, et al. Cardiac Rehabilitation in the Modern Era: Optimizing Recovery and Reducing Recurrence. Cureus. 2023;15(9):e46006. https://doi.org/10.7759/cureus.46006Глазачев О. С., Лямина Н. П., Спирина Г. К. Интервальное гипоксическое кондиционирование: опыт и перспективы применения в программах кардиореабилитации. Российский кардиологический журнал. 2021;26(5):4426. https://doi.org/10.15829/1560-4071-2021-4426Glazachev OS, Lyamina NP, Spirina GK. Intermittent hypoxic conditioning: experience and potential in cardiac rehabilitation programs. Russian Journal of Cardiology. 2021;26(5):4426. (In Russ.). https://doi.org/10.15829/1560-4071-2021-4426Athmuri D.N., Bhattacharyya J., Bhatnagar N., Shiekh P.A. Alleviating hypoxia and oxidative stress for treatment of cardiovascular diseases: a biomaterials perspective. J. Mater. Chem. B. 2024;12(41):10490– 10515. https://doi.org/10.1039/d4tb01126kAthmuri DN, Bhattacharyya J, Bhatnagar N, Shiekh PA. Alleviating hypoxia and oxidative stress for treatment of cardiovascular diseases: a biomaterials perspective. J Mater Chem B. 2024;12(41):10490–10515. https://doi.org/10.1039/d4tb01126kUzun A.B., Iliescu M.G., Stanciu L.E., Ionescu E.V., Ungur R.A., Ciortea V.M., et al. Effectiveness of Intermittent Hypoxia-Hyperoxia Therapy in Different Pathologies with Possible Metabolic Implications. Metabolites. 2023;13(2):181. https://doi.org/10.3390/metabo13020181Uzun AB, Iliescu MG, Stanciu LE, Ionescu EV, Ungur RA, Ciortea VM, et al. Effectiveness of Intermittent Hypoxia-Hyperoxia Therapy in Different Pathologies with Possible Metabolic Implications. Metabolites. 2023;13(2):181. https://doi.org/10.3390/metabo13020181Glazachev O., Kopylov P., Susta D., Dudnik E., Zagaynaya E. Adaptations following an intermittent hypoxia-hyperoxia training in coronary artery disease patients: a controlled study. Clin. Cardiol. 2017;40(6):370–376. https://doi.org/10.1002/clc.22670Glazachev O, Kopylov P, Susta D, Dudnik E, Zagaynaya E. Adaptations following an intermittent hypoxia-hyperoxia training in coronary artery disease patients: a controlled study. Clin Cardiol. 2017;40(6):370–376. https://doi.org/10.1002/clc.22670Sasidharan R., Schippers J.H.M., Schmidt R.R. Redox and low-oxygen stress: signal integration and interplay. Plant. Physiol. 2021;186(1):66– 78. https://doi.org/10.1093/plphys/kiaa081Sasidharan R, Schippers JHM, Schmidt RR. Redox and low-oxygen stress: signal integration and interplay. Plant Physiol. 2021;186(1):66– 78. https://doi.org/10.1093/plphys/kiaa081Yang C., Zhong Z.F., Wang S.P., Vong C.T., Yu B., Wang Y.T. HIF- 1: structure, biology and natural modulators. Chin. J. Nat. Med.2021;19(7):521–527. https://doi.org/10.1016/S1875-5364(21)60051-1Yang C, Zhong ZF, Wang SP, Vong CT, Yu B, Wang YT. HIF-1: structure, biology and natural modulators. Chin J Nat Med. 2021;19(7):521–527. https://doi.org/10.1016/S1875-5364(21)60051-1Pugh C.W., Ratcliffe P.J. New horizons in hypoxia signaling pathways. Exp. Cell. Res. 2017;356(2):116–121. https://doi.org/10.1016/j.yexcr.2017.03.008Pugh CW, Ratcliffe PJ. New horizons in hypoxia signaling pathways. Exp Cell Res. 2017;356(2):116–121. https://doi.org/10.1016/j.yexcr.2017.03.008Hadanny A., Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10(6):958. https://doi.org/10.3390/biom10060958Hadanny A, Efrati S. The hyperoxic-hypoxic paradox. Biomolecules. 2020;10(6):958. https://doi.org/10.3390/biom10060958Bestavashvili A., Glazachev O., Bestavashvili A., Suvorov A., Zhang Y., Zhang X., et al. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile. Biomedicines. 2022;10(3):566. https://doi.org/10.3390/biomedicines10030566Bestavashvili A, Glazachev O, Bestavashvili A, Suvorov A, Zhang Y, Zhang X et al. Intermittent Hypoxic-Hyperoxic Exposures Effects in Patients with Metabolic Syndrome: Correction of Cardiovascular and Metabolic Profile. Biomedicines. 2022;10(3):566. https://doi.org/10.3390/biomedicines10030566Bayer U., Likar R., Pinter G., Stettner H., Demschar S., Trummer B. et al. Effects of intermittent hypoxia-hyperoxia on mobility and perceived health in geriatric patients performing a multimodal training intervention: a randomized controlled trial. BMC Geriatr. 2019;19(1):167. https://doi.org/10.1186/s12877-019-1184-1Bayer U, Likar R, Pinter G, Stettner H, Demschar S, Trummer B, et al. Effects of intermittent hypoxia-hyperoxia on mobility and perceived health in geriatric patients performing a multimodal training intervention: a randomized controlled trial. BMC Geriatr. 2019;19(1):167. https://doi.org/10.1186/s12877-019-1184-1Сахарчук А. Ю., Егле А. П., Черенева Л. А., Лебедева Н. Б., Аргунова Ю. А. Эффекты ре-окси терапии у пациентов, перенесших коронарное шунтирование. 13-й Евразийский конгресс кардиологов: сб. тез. М.: ИнтерМедсервис, 2025:65. https://doi.org/10.38109/ECC_2025Saharchuk AYu, Egle AP, Chereneva LA, Lebedeva NB. Effects of reoxy therapy in patients who have undergone coronary artery bypass surgery. XIII Eurasian Congress of Cardiologists. Abstracts. 2025;65. (In Russ.). https://doi.org/10.38109/ECC_2025Serebrovskaya T.V., Xi L. Intermittent hypoxia training as non-pharmacologic therapy for cardiovascular diseases: Practical analysis on methods and equipment. Exp. Biol. Med. (Maywood). 2016;241(15):1708– 1723. https://doi.org/10.1177/1535370216657614Serebrovskaya TV, Xi L. Intermittent hypoxia training as nonpharmacologic therapy for cardiovascular diseases: Practical analysis on methods and equipment. Exp Biol Med (Maywood). 2016;241(15):1708–1723. https://doi.org/10.1177/1535370216657614Tuter D.S., Kopylov P.Y., Syrkin A.L., Glazachev O.S., Komarov R.N., Katkov A.I., et al. Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial. Open Heart. 2018;5:e000891. https://doi.org/10.1136/openhrt-2018-000891Tuter DS, Kopylov PY, Syrkin AL, Glazachev OS, Komarov RN, Katkov AI, et al. Intermittent systemic hypoxic–hyperoxic training for myocardial protection in patients undergoing coronary artery bypass surgery: first results from a single-centre, randomised controlled trial. Open Heart. 2018;5:e000891. https://doi.org/10.1136/openhrt-2018-000891Doehner W., Fischer A., Alimi B., Muhar J., Springer J., et al. Intermittent Hypoxic-Hyperoxic Training During Inpatient Rehabilitation Improves Exercise Capacity and Functional Outcome in Patients With Long Covid: Results of a Controlled Clinical Pilot Trial. J. Cachexia Sarcopenia Muscle. 2024;15(6):2781–2791. https://doi.org/10.1002/jcsm.13628Doehner W, Fischer A, Alimi B, Muhar J, Springer J, Altmann C, et al. Intermittent Hypoxic-Hyperoxic Training During Inpatient Rehabilitation Improves Exercise Capacity and Functional Outcome in Patients With Long Covid: Results of a Controlled Clinical Pilot Trial. J Cachexia Sarcopenia Muscle. 2024;15(6):2781–2791. https://doi.org/10.1002/jcsm.13628Ойноткинова О. Ш., Мацкеплишвили С. Т., Масленникова О. М., Ершов А. А. Комплексные подходы к коррекции сердечно-сосудистых показателей и митохондриальной дисфункции при метаболическом синдроме методом гипо-гипероксических тренировок. Эффективная фармакотерапия. 2024;20(26):14–23.https://doi.org/10.33978/2307-3586-2024-20-26-14-23Oynotkinova OSh, Matskeplishvili ST, Maslennikova OM, Yershov AA. Comprehensive Approaches to the Correction of Cardiovascular Parameters and Mitochondrial Dysfunction in Metabolic Syndrome by the Method of Hypoxic-Hyperoxic Training. Effective Pharmacotherapy. 2024;20(26):14–23. (In Russ.). https://doi.org/10.33978/2307-3586-2024-20-26-14-23Tian M., Du W., Yang S., Liao Q., Guo F., Li S. Application and progress of hyperbaric oxygen therapy in cardiovascular diseases. Med. Gas. Res. 2025;15(3):427–434. https://doi.org/10.4103/mgr.MEDGASRES-D-24-00107Tian M, Du W, Yang S, Liao Q, Guo F, Li S. Application and progress of hyperbaric oxygen therapy in cardiovascular diseases. Med Gas Res. 2025;15(3):427–434. https://doi.org/10.4103/mgr.MEDGASRES-D-24-00107Загайная Е. Э., Копылов Ф. Ю., Глазачев О. С., Дудник Е. Н., Быкова А. А., Тутер Д. С. и др. Качество жизни пациентов со стабильной стенокардией напряжения при применении интервальных гипоксических-гипероксических тренировок. Кардиология и сердечно-сосудистая хирургия. 2016;9(3):21–27. https://doi.org/10.17116/kardio20169321-27Zagaĭnaia E, Kopylov FIu, Glazachev OS, Dudnik EN, Bykova AA, Tuter DS, et al. Quality of life in patients with stable angina in application of intermittent hypoxic-hyperoxic training. Russian Journal of Cardiology and Cardiovascular Surgery. 2016;9(3):21‑27. (In Russ.). https://doi.org/10.17116/kardio20169321-27Uzun A.B., Nedelcu A.D., Stanciu L.E., Iliescu M.G., Tofolean I.D. The Impact of Intermittent Hypoxia-Hyperoxia Therapy on Cardiovascular and Respiratory Parameters. Journal ARS Medica Tomitana. 2023;1(29):18-24. https://doi.org/10.2478/arsm-2023-0004Uzun AB, Nedelcu AD, Stanciu LE, Iliescu MG, Tofolean ID. The Impact of Intermittent Hypoxia-Hyperoxia Therapy on Cardiovascular and Respiratory Parameters. Journal ARS Medica Tomitana. 2023;1(29):18–24. https://doi.org/10.2478/arsm-2023-0004Zebrowska A., Nowak-Lis A., Nowak Z., Hall B. Normobaric hypoxia and exercise training effects on cardiac biomarkers, left ventricular function and aerobic performance in patients after myocardial infarction. European Heart Journal. 2023;44(Suppl 2). https://doi.org/10.1093/eurheartj/ehad655.2397Zebrowska A, Nowak-Lis A, Nowak Z, Hall B. Normobaric hypoxia and exercise training effects on cardiac biomarkers, left ventricular function and aerobic performance in patients after myocardial infarction. European Heart Journal. 2023;44(Suppl 2). https://doi.org/10.1093/eurheartj/ehad655.2397.

The authors declare that there are no conflicts of interest present.